Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: Rationale and design of the STEMI-DTU randomized pivotal trial - 06/12/22
, Raymond J. Kim, MD b, Jeffrey W. Moses, MD c, e, Gregg W. Stone, MD d, James E. Udelson, MD a, Ori Ben-Yehuda, MD e, Bjorn Redfors, MD, PhD e, Melek Ozgu Issever, MS e, Noam Josephy, MD, MSc, MBA f, g, Samantha J. Polak, MD, PhD f, William W. O'Neill, MD hABSTRACT |
Background |
Despite successful primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI), myocardial salvage is often suboptimal, resulting in large infarct size and increased rates of heart failure and mortality. Unloading of the left ventricle (LV) before primary PCI may reduce infarct size and improve prognosis.
Study design and objectives |
STEMI-DTU (NCT03947619) is a prospective, randomized, multicenter trial designed to compare mechanical LV unloading with the Impella CP device for 30 minutes prior to primary PCI to primary PCI alone without LV unloading. The trial aims to enroll approximately 668 subjects, with a potential sample size adaptation, with anterior STEMI with a primary end point of infarct size as a percent of LV mass evaluated by cardiac magnetic resonance at 3-5 days after PCI. The key secondary efficacy end point is a hierarchical composite of the 1-year rates of cardiovascular mortality, cardiogenic shock ≥24 hours after PCI, use of a surgical left ventricular assist device or heart transplant, heart failure, intra-cardiac defibrillator or chronic resynchronization therapy placement, and infarct size at 3 to 5 days post-PCI. The key secondary safety end point is Impella CP-related major bleeding or major vascular complications within 30 days. Clinical follow-up is planned for 5 years.
Conclusions |
STEMI-DTU is a large-scale, prospective, randomized trial evaluating whether mechanical unloading of the LV by the Impella CP prior to primary PCI reduces infarct size and improves prognosis in patients with STEMI compared to primary PCI alone without LV unloading.
Le texte complet de cet article est disponible en PDF.Plan
Vol 254
P. 122-132 - décembre 2022 Retour au numéro
Article précédent
- Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry
- Daniel J. Friedman, Dominique Pierre, Yongfei Wang, Louise Gambone, Christina Koutras, Claire Segawa, Andrew Farb, Sreekanth Vemulapalli, Paul D. Varosy, Frederick A. Masoudi, Alexandra Lansky, Jeptha P. Curtis, James V. Freeman
- Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale
- Pablo B. Nery, George A. Wells, Atul Verma, Jacqueline Joza, Girish M. Nair, George Veenhuyzen, Jason Andrade, Isabelle Nault, Jorge A. Wong, Markus Sikkel, Vidal Essebag, Laurent Macle, John Sapp, Jean-Francois Roux, Allan Skanes, Paul Angaran, Paul Novak, Damian Redfearn, Mehrdad Golian, Calum J. Redpath, Marcio Sturmer, David Birnie
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?